Showing results (1381-1390 of 1,543) with videos related to

Sort By:
Pageof 155
Animals : an Open Access Journal From MDPI|March 22, 2019
Evaluation of Black Soldier Fly (Hermetia illucens) Larvae and Pre-Pupae Raised on Household Organic Waste, as Potential Ingredients for Poultry FeedKiyonori Kawasaki, Yuka Hashimoto, Akihiro Hori, et al.
Journal of Diabetes Investigation|March 25, 2015
Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot studyTakahiro Watanabe, Yoshifumi Tamura, Saori Kakehi, et al.
Diabetologia|September 9, 2021
Characterisation of Ppy-lineage cells clarifies the functional heterogeneity of pancreatic beta cells in miceTakahiro Fukaishi, Yuko Nakagawa, Ayako Fukunaka, et al.
Molecular and Cellular Biology|May 8, 2001
Mutations in the novel membrane protein spinster interfere with programmed cell death and cause neural degeneration in Drosophila melanogasterY Nakano, K Fujitani, J Kurihara, et al.
Endocrine Journal|April 13, 2018
Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP studyHiromasa Goto, Tomoya Mita, Yoshio Fujitani, et al.
The Journal of Pathology|June 5, 2024
Identification of Ppy-lineage cells as a novel origin of pancreatic ductal adenocarcinomaOfejiro Blessing Pereye, Yuko Nakagawa, Takashi Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Analysis of Esophageal Cancer Patients Undergoing Non-Curative Resection]Akihiro Kitagawa, Junji Kawada, Masaaki Motoori, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2025
[Case Report of a Patient Who Underwent Open Left Hepatic Lobectomy Followed by Robot-Assisted High-Anterior Resection after Preoperative Chemotherapy for Multiple Simultaneous Liver Metastases of Rectal Cancer]Kento Nakamori, Yoshinori Kagawa, Yuki Ozato, et al.
Journal of Biochemistry|February 13, 2023
PPARα activation partially drives NAFLD development in liver-specific Hnf4a-null miceCarlos Ichiro Kasano-Camones, Masayuki Takizawa, Noriyasu Ohshima, et al.
International Journal of Clinical Oncology|June 5, 2020
Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trialsHisato Kawakami, Kazumasa Fujitani, Jin Matsuyama, et al.
Pageof 155